-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On Tuesday, Johnson & Johnson won a major appeal in an opioid marketing case in Oklahoma, USA
.
The Supreme Court of Oklahoma in the United States overturned a lower court’s previous judgment of $465 million against Johnson & Johnson.
The ruling at the time held that Johnson & Johnson’s opioid marketing was suspected of causing public nuisance in the state
.
According to the latest news, the Oklahoma Supreme Court voted 5-1.
Judge James Winchester wrote in his opinion that the central focus of the state’s complaint is that Johnson & Johnson has or should have been aware of the seriousness of the matter, and that Johnson & Johnson has failed to clearly warn about the promotion and marketing of its opioids related to opioid abuse and addiction.
The product is dangerous, and the product responsibility is not fulfilled
.
But Winchester stated that nuisance laws and product-related liability are "two different reasons for litigation, and both reasons have non-overlapping boundaries
As early as 2019, Judge Thad Balkman of Cleveland County, Oklahoma sentenced Johnson & Johnson to deliberately downplay the risks and exaggerate the benefits of opioids, causing the state's opioid addiction crisis.
Johnson & Johnson was sentenced to $572 million in compensation
.
Later, due to errors in the previous calculations, he revised the fine to 465 million US dollars, which will be used to reduce medical expenses caused by the opioid epidemic
Thad Balkman wrote in the ruling that behind the increase in opioid sales in Oklahoma, the simultaneous increase in opioid addiction and overdose deaths is not a coincidence
.
From 1994 to 2006, the sales of prescription opioids increased fourfold
Since then, Johnson & Johnson has been busy resolving complex national opioid lawsuits
.
Johnson & Johnson and other companies are facing thousands of opioid lawsuits from states, cities, counties, and other organizations.
In addition to opioids, Johnson & Johnson also suffers from the "torture" of baby powder
.
Since baby powder and other products are accused of causing cancer risks, Johnson & Johnson has faced various lawsuits as many as 38,000.
Original English: https:// href="https://" target="_blank">https://
